结论：卡培他滨和奥沙利铂用于先前未经治疗的食管癌和胃癌患者，效果分别与氟尿嘧啶和顺铂相同。
Conclusions Capecitabine and oxaliplatin are as effective as fluorouracil and cisplatin, respectively, in patients with previously untreated esophagogastric cancer.
该研究计划入组600例食道癌、贲门癌和胃癌患者，早期的缓解率数据有益于应用含卡培他滨和奥沙利铂的患者，但这只是初步的结果。
This study intends to accrue 600 patients with esophagus, GE-junction, and stomach cancer. Early response data favor the use of capecitabine and oxaliplatin, but the data are preliminary .
该研究计划入组600例食道癌、贲门癌和胃癌患者，早期的缓解率数据有益于应用含卡培他滨和奥沙利铂的患者，但这只是初步的结果。
This study intends to accrue 600 patients with esophagus, GE-junction, and stomach cancer. Early response data favor the use of capecitabine and oxaliplatin, but the data are preliminary .
应用推荐